HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Geoffrey M Lynn Selected Research

Geoffrey M Lynn Research Topics

Disease

9Neoplasms (Cancer)
05/2024 - 12/2017
2Human Influenza (Influenza)
01/2023 - 10/2016
2Malaria
01/2016 - 03/2015
1Brain Neoplasms (Brain Tumor)
01/2019
1Infections
01/2016
1Parasitemia
01/2016
1Tuberculosis (Tuberculoses)
03/2015
1Bites and Stings (Sting)
03/2015

Drug/Important Bio-Agent (IBA)

7VaccinesIBA
05/2024 - 03/2015
5AntigensIBA
05/2024 - 03/2015
4Peptides (Polypeptides)IBA
05/2024 - 11/2022
4Cancer VaccinesIBA
11/2022 - 01/2020
2NanovaccinesIBA
05/2024 - 11/2022
2Neoplasm Antigens (Tumor Antigens)IBA
11/2022 - 01/2021
1Toll-Like Receptor AgonistsIBA
05/2024
1RNA (Ribonucleic Acid)IBA
01/2023
1Interferon Type IIBA
11/2022
1Toll-Like Receptor 7IBA
11/2022
1Immune Checkpoint InhibitorsIBA
10/2019
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
10/2019
1MicellesIBA
10/2019
1PolymersIBA
10/2019
1AlbuminsIBA
12/2017
1Subunit VaccinesIBA
12/2017
1Synthetic Vaccines (Recombinant Vaccines)IBA
12/2017
1Evans Blue (Blue, Evans)FDA Link
12/2017
1Albumin-Bound PaclitaxelFDA Link
12/2017
1Neutralizing AntibodiesIBA
10/2016
1EpitopesIBA
10/2016
11- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA
01/2016

Therapy/Procedure

6Immunotherapy
05/2024 - 12/2017
2Therapeutics
01/2021 - 01/2019
1Oncolytic Virotherapy
05/2024
1Drug Therapy (Chemotherapy)
01/2021
1Intravenous Administration
10/2019